Although studying the genetics of renal glucosuria has some value when understanding a generally benign trait associated with some clinical outcomes, the greatest value may be related to better treatments for those taking an SGLT2 inhibitor designed to artificially induce glucosuria. This evidence concerns the gene SLC5A2 and Renal glucosuria.